Key terms
About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PFE news
May 24
11:18am ET
Biotech Alert: Searches spiking for these stocks today
May 23
10:41am ET
Biotech Alert: Searches spiking for these stocks today
May 23
8:55am ET
Notable open interest changes for May 23rd
May 22
5:30pm ET
Moderna and Pfizer in talks with U.S. on HSN1 bird flu vaccine, Reuters says
May 22
5:01pm ET
Pfizer cost update an incremental positive, says Morgan Stanley
May 22
3:48pm ET
Pfizer cost reduction program a positive for the shares, says BMO
May 22
12:46pm ET
Pfizer sees $1.7B of costs in 2024 from first phase of program
May 22
5:45am ET
Wells Fargo Remains a Hold on Pfizer (PFE)
May 17
11:42am ET
Moderna wins European patent case in Pfizer, BioNTech dispute, FT reports
May 16
6:09am ET
Arvinas,Pfizer update Phase 1b data on vepdegestrant palbociclib combination
May 15
10:09am ET
Jefferies retail/healthcare analysts to hold an analyst/industry conference call
May 14
7:39am ET
Syros Pharmaceuticals reports Q1 EPS (10c), consensus (86c)
May 13
3:58pm ET
Novavax (NASDAQ:NVAX) Explodes Upward 50% After Sanofi Deal
May 09
9:40am ET
Unusually active option classes on open May 9th
May 08
10:26am ET
Pfizer agrees to settle over 10,000 Zantac cancer suits, Bloomberg reports
May 07
3:33pm ET
Young boy dies in trial of Pfizer DMD gene therapy, STAT reports
May 06
6:49am ET
Pfizer appoints Andrew Baum as Chief Strategy and Innovation Officer
May 03
9:28am ET
Moderna price target raised to $155 from $125 at Jefferies
May 02
4:10pm ET
Analysts Conflicted on These Healthcare Names: InMode (INMD) and Pfizer (PFE)
May 02
11:06am ET
Genmab reports Q1 revenue increased 46% vs. last year
May 02
7:58am ET
Pfizer price target raised to $29 from $28 at Morgan Stanley
May 02
7:38am ET
Pfizer Exceeds Q1 Expectations with Strong Earnings and Raises 2024 Guidance: A Buy Rating by Evan Seigerman
May 02
6:32am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Alkermes (ALKS)
May 02
5:20am ET
Pfizer’s Mixed Financial Signals: A Delicate Balance Between Growth and Uncertainty
May 02
3:50am ET
Pfizer (PFE) Receives a Hold from Barclays
May 02
1:15am ET
Buy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost Savings
May 01
4:35pm ET
Jefferies Remains a Buy on Pfizer (PFE)
May 01
9:44am ET
PFE Earnings: Pfizer Rises on Smashing Q1 Estimates
May 01
9:05am ET
UBS Reaffirms Their Hold Rating on Pfizer (PFE)
May 01
9:05am ET
Analysts Offer Insights on Healthcare Companies: SurModics (SRDX) and Pfizer (PFE)
May 01
7:05am ET
Options Volatility and Implied Earnings Moves Today, May 01, 2024
No recent press releases are available for PFE
PFE Financials
Key terms
Ad Feedback
PFE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PFE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
